Geode Capital Management’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCY
IAIM
Geode Capital Management's ONCY Position: Q3 2026 in Review
Geode Capital Management sold out of Oncolytics Biotech (ONCY) in Q3 2026, closing a stake of 66,939 shares — an estimated $63.6K sold.
Geode Capital Management first reported a position in ONCY in Q3 2020 and held it in 24 quarters. The position peaked at $93.7K in Q3 2025. 51 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.
- Geode Capital Management reported no remaining Oncolytics Biotech position as of Q3 2026 after selling out during the quarter.
- Geode Capital Management sold 66,939 Oncolytics Biotech shares in Q3 2026, an estimated $63.6K.
- Geode Capital Management first reported a position in Oncolytics Biotech in Q3 2020 and held it in 24 quarters.
- Geode Capital Management's Oncolytics Biotech position peaked at $93.7K in Q3 2025.
- 51 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.